New diabetes clinical trial: Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US

Published on: 2026-02-24T05:00:00Z
Conditions: Overweight or Obesity
Interventions: Drug: Olatorepatide; Drug: Placebo
Sponsors: Regeneron Pharmaceuticals
Not yet recruiting
https://ift.tt/cKdagGW